AYUSH press release · 18 May 2026 · pibtracker filter

Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) Organizes 5-Day Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders

PRID2262543 MinistryAYUSH Released18 May 2026 Reading11 min

Training Program focuses on strengthening quality standards, regulatory knowledge and technical capabilities in ASU&H sector Posted On: 18 MAY 2026 8:59PM by PIB Delhi The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines. The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development. The inaugural session of the programme was graced by Ms. Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity. Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine. Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines. During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs. Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry. The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units. This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India’s leadership in the global regulation, standardization and development of traditional systems of medicine. *** SR/SV/SG (Release ID: 2262543) Visitor Counter : 664 Read this release in: Urdu , हिन्दी , Tamil AYUSH Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) Organizes 5-Day Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders Training Program focuses on strengthening quality standards, regulatory knowledge and technical capabilities in ASU&H sector Posted On: 18 MAY 2026 8:59PM by PIB Delhi The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines. The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development. The inaugural session of the programme was graced by Ms. Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity. Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine. Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines. During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs. Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry. The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units. This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India’s leadership in the global regulation, standardization and development of traditional systems of medicine. *** SR/SV/SG (Release ID: 2262543) Training Program focuses on strengthening quality standards, regulatory knowledge and technical capabilities in ASU&H sector" /> The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H), Ministry of Ayush, is organizing a five-day Capacity Building Training Program from 18th to 22nd May 2026. The programme is being conducted for drug regulators, enforcement authorities, quality control personnel, technical experts, faculty members, government analysts, researchers and scientists working in the field of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) medicines. The programme aims to strengthen the knowledge, technical skills and professional capabilities of stakeholders associated with the regulatory, academic, quality control and manufacturing sectors of ASU&H drug development. The inaugural session of the programme was graced by Ms. Jaspal Kaur Pradyot, Chief Controller of Accounts, Ministry of Health & Family Welfare, as the Chief Guest. In her address, she appreciated PCIM&H for its significant contribution towards the development of quality standards for ASU&H drugs through the adoption of modern instruments and advanced scientific techniques. She also highlighted the rich heritage of AYUSH systems of medicine and their growing global acceptance and popularity. Dr. Abdul Qayum, Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush, attended the programme as the Guest of Honour. He emphasized the international recognition of the pharmacopoeias and formularies developed by PCIM&H and noted the increasing global demand and acceptance of ASU&H systems of medicine. Welcoming the dignitaries and participants, Dr. Raman Mohan Singh, Director, PCIM&H, provided an overview of the organization and highlighted its key activities in the standardization and quality control of ASU&H medicines. During the five-day programme, participants will receive expert-led lectures on various important aspects including NABL Accreditation and Quality Management Systems (QMS), Good Manufacturing Practices (GMP), pharmacognostic, physico-chemical, phytochemical, microbiological and pharmacological evaluation of ASU&H drugs, standardization and quality control of herbal drugs, regulatory and pharmacopoeial aspects of ASU&H medicines, and shelf-life studies of ASU&H drugs. Participants will also undergo hands-on laboratory training at PCIM&H and participate in field visits to leading ASU&H drug manufacturing units, including Dr. Willmar Schwabe India Pvt. Ltd., Noida, and Hamdard Laboratories India, Ghaziabad. These visits are aimed at providing practical exposure to modern technologies, manufacturing practices and quality assurance systems adopted in the industry. The programme has attracted 28 participants from across the country representing a diverse range of institutions and organizations, including State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, AYUSH-accredited Drug Testing Laboratories, National Institutes and Research Centres such as the National Institute of Siddha, Chennai; Siddha Central Research Institute, Chennai; Central Drugs Laboratory, Kolkata; Regional Ayurveda Research Institute (CCRAS), Jammu and Jhansi; and ASU&H drug manufacturing units. This Capacity Building Training Program is a significant initiative by PCIM&H aimed at promoting professional excellence and strengthening quality standards within the ASU&H sector. By equipping stakeholders with updated technical knowledge and practical expertise, the programme seeks to further reinforce India’s leadership in the global regulation, standardization and development of traditional systems of medicine. <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image001AUYN.jpg" style="height:349px; width:566px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image0029W8T.jpg" style="height:385px; width:573px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image0030IL9.jpg" style="height:375px; width:566px" /> *** SR/SV/SG " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //

Original PIB release
pib.gov.in · PRID 2262543

Open on PIB ↗

Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) Organizes 5-Day Capacity Building Training Program for ASU&H Drug Regulators and Stakeholders

More from this day